Aandeel ZIM ZIMMER BIOMET HOLDINGS, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Zimmer Biomet Holdings, Inc. Deutsche Boerse AG

Aandelen

ZIM

US98956P1021

Geschatte realtime Tradegate
Andere beurzen
 11:21:28 27-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
101,1 EUR +0,42% Intraday-grafiek van Zimmer Biomet Holdings, Inc. +1,65% -8,38%
20/06 Zimmer Biomet Holdings, Inc. Benoemt Devdatt Kurdikar tot lid van de Raad van Bestuur CI
12/06 Zimmer Biomet sluit co-marketingovereenkomst met RevelAi Health MT

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors
THINK Surgical Enters Distribution Agreement with Zimmer Biomet
RevelAi Health and Zimmer Biomet Announce Exclusive Multi-Year, Co-Marketing Agreement to Advance Value Based Care and Health Equity through AI-Powered Technology
Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI Miniature Handheld Robotic System for Total Knee Arthroplasty
RevelAi Health and Zimmer Biomet Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value-Based Care and Health Equity through AI-Powered Technology
RevelAi Health and Zimmer Biomet Holdings, Inc. Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value-Based Care and Health Equity Through AI-Powered Technology
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI® Miniature Handheld Robotic System for Total Knee Arthroplasty
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI Miniature Handheld Robotic System for Total Knee Arthroplasty
Osteal Therapeutics, Inc. announced that it has received $50 million in funding from Zimmer Biomet Holdings, Inc., Johnson & Johnson Innovation - JJDC, Inc., HM Capital Management, LLC, GIDEON STRATEGIC PARTNERS LLC and other investors
Zimmer Biomet Holdings Insider Sold Shares Worth $1,474,582, According to a Recent SEC Filing
Zimmer Biomet to Present at the Goldman Sachs 45th Annual Healthcare Conference
Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says
EE.UU. - Valores a seguir en Wall Street (actualizado)
Zimmer Biomet Outlines Growth Strategy Through 2027; Board Approves $2 Billion Stock Buyback
Zimmer Biomet Outlines Strategy to Deliver Above Market Growth at 2024 Investor Day
Zimmer Biomet Holdings, Inc. announces an Equity Buyback for $2,000 million worth of its shares.
Zimmer Biomet Holdings, Inc. authorizes a Buyback Plan.
Deepull appoints Didier Deltort to its Board of Directors
Osteal Therapeutics, Inc. announced that it expects to receive funding
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers ZBH
  4. Koers ZIM
  5. Nieuws Zimmer Biomet Holdings, Inc.
  6. Andere talen